Aurinia Pharmaceuticals Inc. (AUPH)

Latest Insider Confidence Score

2026Q1

52.7
Bullish

Company insider confidence (by quarter)

2021Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Tang Kevin Director 11,329,500 Aug 5, 2025
Habig Scott Michael Chief Commercial Officer 456,338 Aug 8, 2024
Greenleaf Peter CEO 443,973 Mar 4, 2025
Knappertz Volker EVP, Research and Development 319,128 Feb 29, 2024
Colao Massimilano Chief Commercial Officer 282,143 Mar 4, 2022

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 3, 2026 TANG KEVIN Director Buy 97.5 +900,000 7.94% ✗ $12.7M
Feb 27, 2026 Mar 3, 2026 Miller Joseph M CFO Sell 90.0 +19,718 3.54% ✗ $533K
Feb 27, 2026 Mar 3, 2026 Donley Matthew Maxwell COO Sell 90.0 +17,399 2.62% ✗ $579.2K
Feb 27, 2026 Mar 3, 2026 Greenleaf Peter CEO Sell 95.0 +95,513 5.47% ✗ $1.4M
Feb 27, 2026 Mar 3, 2026 Keenan Greg SVP, Chief Medical Officer Neutral 90.0 +40,586 33.29% ✗ -
Feb 27, 2026 Mar 3, 2026 Robertson Stephen P. EVP, General Counsel Sell 90.0 +22,565 4.67% ✗ $519K
Feb 20, 2026 Feb 23, 2026 Donley Matthew Maxwell COO Sell 40.0 -32,901 -4.73% ✗ $473.8K
Feb 20, 2026 Feb 23, 2026 Greenleaf Peter CEO Sell 37.5 -100,171 -5.43% ✗ $1.4M
Feb 20, 2026 Feb 23, 2026 Miller Joseph M CFO Sell 40.0 -32,424 -5.50% ✗ $466.9K
Feb 20, 2026 Feb 23, 2026 Robertson Stephen P. EVP, General Counsel Sell 40.0 -34,638 -6.69% ✗ $498.8K
Feb 2, 2026 Feb 3, 2026 Keenan Greg SVP, Chief Medical Officer Sell 42.5 -11,552 -8.65% ✗ $167.9K
Jan 2, 2026 Jan 5, 2026 Robertson Stephen P. EVP, General Counsel Sell 75.0 +8,173 0.77% ✗ $644.1K
Jan 2, 2026 Jan 5, 2026 Donley Matthew Maxwell COO Sell 75.0 +11,379 0.80% ✗ $682.5K
Jan 2, 2026 Jan 5, 2026 Miller Joseph M CFO Sell 75.0 +8,877 0.74% ✗ $640.6K
Jan 2, 2026 Jan 5, 2026 Greenleaf Peter CEO Sell 87.5 +52,215 1.39% ✗ $1.8M
Nov 21, 2025 Nov 24, 2025 Bailey Jeffrey Allen Director Sell 46.3 -2,716 -10.65% ✗ $42.6K
Nov 21, 2025 Nov 24, 2025 Johnson Craig A Director Sell 42.5 -6,039 -29.27% ✗ $94.7K
Aug 1, 2025 Aug 5, 2025 TANG KEVIN Director Buy 100.0 +1,300,000 12.96% ✗ $13.6M
Aug 1, 2025 Aug 5, 2025 Keenan Greg Chief Medical Officer Sell 22.5 -20,000 -13.03% ✗ $210K
May 16, 2025 May 16, 2025 Nova Tina Susan Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 16, 2025 Johnson Craig A Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 16, 2025 Goetz Kathleen Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 May 16, 2025 Bailey Jeffrey Allen Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 Nova Tina Susan Director Neutral 52.5 - 0.00% ✗ -
May 16, 2025 Goetz Kathleen Director Neutral 52.5 - 0.00% ✗ -
Mar 7, 2025 Mar 7, 2025 Keenan Greg Chief Medical Officer Sell 42.5 -8,305 -5.13% ✗ $68.4K
Feb 28, 2025 Mar 4, 2025 Greenleaf Peter CEO Sell 100.0 +263,893 17.30% ✗ $2.9M
Feb 28, 2025 Mar 4, 2025 Keenan Greg Chief Medical Officer Sell 95.0 +50,344 45.17% ✗ $97.9K
Feb 28, 2025 Mar 4, 2025 Miller Joseph M CFO Sell 97.5 +78,155 15.66% ✗ $939.6K
Feb 28, 2025 Mar 4, 2025 Robertson Stephen P. EVP, General Counsel Sell 97.5 +64,033 14.38% ✗ $975.2K
Feb 28, 2025 Mar 4, 2025 Donley Matthew Maxwell COO Sell 97.5 +93,455 15.92% ✗ $994.4K
Feb 28, 2025 Mar 4, 2025 TANG KEVIN Director Buy 100.0 +1,600,000 18.98% ✗ $12.7M
Dec 5, 2024 Dec 9, 2024 TANG KEVIN Director Buy 100.0 +1,200,000 16.60% ✗ $10.8M
Nov 21, 2024 Nov 25, 2024 Smith Karen L. Director Neutral 90.0 +12,135 95.76% ✗ -
Nov 21, 2024 Nov 25, 2024 Leversage Jill Director Neutral 90.0 +12,135 93.94% ✗ -
Nov 21, 2024 Nov 25, 2024 Johnson Craig A Director Neutral 90.0 +20,631 100.00% ✗ -
Nov 21, 2024 Nov 25, 2024 Bailey Jeffrey Allen Director Neutral 90.0 +12,135 90.86% ✗ -
Nov 21, 2024 Nov 25, 2024 Jayne David R.W. Director Neutral 90.0 +12,135 27.35% ✗ -
Nov 8, 2024 Nov 12, 2024 Bailey Jeffrey Allen Director Sell 46.3 -4,557 -25.44% ✗ $38.4K
Nov 8, 2024 Nov 12, 2024 Smith Karen L. Director Sell 46.3 -5,241 -29.26% ✗ $44.2K
Nov 12, 2024 Keenan Greg Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 12, 2024 Johnson Craig A Director Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 TANG KEVIN Director Neutral 52.5 - 0.00% ✗ -
Sep 20, 2024 MacKay-Dunn R. Hector Other Neutral 52.5 - 0.00% ✗ -
Aug 6, 2024 Aug 8, 2024 Habig Scott Michael Chief Commercial Officer Sell 42.5 -18,249 -3.85% ✗ $96.9K
May 21, 2024 May 22, 2024 Balakrishnan Brinda Director Sell 47.5 -520 -2.88% ✗ $3K
May 21, 2024 May 22, 2024 Billen Daniel Director Sell 46.3 -5,252 -15.73% ✗ $30.1K
May 21, 2024 May 22, 2024 Jayne David R.W. Director Sell 46.3 -4,946 -10.03% ✗ $28.4K
May 21, 2024 May 22, 2024 Leversage Jill Director Sell 46.3 -5,610 -30.28% ✗ $32.2K
May 21, 2024 May 22, 2024 MacKay-Dunn R. Hector Director Sell 46.3 -5,630 -23.24% ✗ $32.3K
Mar 6, 2024 Mar 7, 2024 Greenleaf Peter CEO Sell 40.0 -126,981 -7.70% ✗ $711.1K
Mar 6, 2024 Mar 7, 2024 Miller Joseph M CFO Sell 42.5 -34,811 -6.56% ✗ $194.9K
Mar 6, 2024 Mar 7, 2024 Donley Matthew Maxwell EVP, Ops & Strategy Sell 42.5 -40,665 -6.51% ✗ $224.1K
Mar 6, 2024 Mar 7, 2024 Habig Scott Michael Chief Commercial Officer Sell 42.5 -17,777 -3.61% ✗ $99.6K
Mar 6, 2024 Mar 7, 2024 Robertson Stephen P. EVP, General Counsel Sell 40.0 -57,745 -11.51% ✗ $323.4K
Feb 27, 2024 Feb 29, 2024 Knappertz Volker EVP, Research and Development Sell 26.3 -4,930 -1.52% ✗ $30.1K
Feb 20, 2024 Feb 22, 2024 Knappertz Volker EVP, Research and Development Sell 42.5 -25,146 -7.20% ✗ $137.8K
Feb 20, 2024 Feb 22, 2024 Habig Scott Michael Chief Commercial Officer Sell 95.0 +179,645 57.45% ✗ $87K
Feb 20, 2024 Feb 22, 2024 Donley Matthew Maxwell EVP, Ops & Strategy Neutral 90.0 +216,666 53.10% ✗ -
Feb 20, 2024 Feb 22, 2024 Robertson Stephen P. EVP, General Counsel Neutral 90.0 +194,230 63.20% ✗ -
Feb 20, 2024 Feb 22, 2024 Miller Joseph M CFO Neutral 90.0 +196,153 58.63% ✗ -
Feb 20, 2024 Feb 22, 2024 Greenleaf Peter CEO Neutral 90.0 +661,538 66.99% ✗ -
Mar 2, 2023 Feb 22, 2024 Robertson Stephen P. EVP, General Counsel Sell 42.5 -19,644 -6.09% ✗ $172.5K
Mar 2, 2023 Feb 22, 2024 Miller Joseph M CFO Sell 42.5 -11,398 -3.33% ✗ $100.1K
Mar 2, 2023 Feb 22, 2024 Greenleaf Peter CEO Sell 40.0 -33,047 -3.25% ✗ $290.2K
Sep 21, 2023 Sep 22, 2023 Foster Robert T Director Neutral 52.5 - 0.00% ✗ -
Sep 22, 2023 Foster Robert T Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2023 Aug 21, 2023 Bailey Jeffrey Allen Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2023 Bailey Jeffrey Allen Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2023 Aug 21, 2023 Smith Karen L. Director Neutral 52.5 - 0.00% ✗ -
Aug 21, 2023 Smith Karen L. Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 23, 2023 Balakrishnan Brinda Director Neutral 90.0 +9,310 106.61% ✗ -
May 18, 2023 May 23, 2023 Jayne David R.W. Director Sell 82.5 +577 1.18% ✗ $98.3K
May 18, 2023 May 23, 2023 Hagan Joseph P Director Sell 47.5 -272 -2.22% ✗ $2.9K
May 18, 2023 May 23, 2023 Billen Daniel Director Sell 95.0 +4,660 16.22% ✗ $52.4K
May 18, 2023 May 23, 2023 MILNE GEORGE M JR Director Neutral 52.5 - 0.00% ✗ -
May 18, 2023 May 23, 2023 MacKay-Dunn R. Hector Director Sell 95.0 +4,492 22.76% ✗ $54.3K
May 18, 2023 May 23, 2023 Leversage Jill Director Sell 95.0 +4,495 32.03% ✗ $54.2K
Mar 2, 2023 Mar 6, 2023 MILNE GEORGE M JR Director Buy 95.0 +20,000 40.00% ✗ $178.3K
Mar 2, 2023 Mar 6, 2023 Donley Matthew Maxwell EVP, Ops & Strategy Neutral 90.0 +271,134 205.39% ✗ -
Mar 2, 2023 Mar 6, 2023 Miller Joseph M CFO Sell 95.0 +218,125 192.88% ✗ $101K
Mar 2, 2023 Mar 6, 2023 Robertson Stephen P. EVP, General Counsel Sell 95.0 +185,408 157.18% ✗ $173.5K
Mar 2, 2023 Mar 6, 2023 Martin Michael Robert Chief Business Officer Neutral 90.0 +107,202 70.55% ✗ -
Mar 2, 2023 Mar 6, 2023 Habig Scott Michael Chief Commercial Officer Neutral 90.0 +170,188 119.40% ✗ -
Mar 2, 2023 Mar 6, 2023 Knappertz Volker EVP, Research and Development Neutral 90.0 +191,462 125.29% ✗ -
Mar 2, 2023 Mar 6, 2023 Greenleaf Peter CEO Sell 97.5 +634,657 182.21% ✗ $292.8K
Nov 21, 2022 Nov 23, 2022 Donley Matthew Maxwell Ex VP, Internal Operations Buy 91.3 +10,000 55.78% ✗ $46.6K
Nov 9, 2022 Nov 14, 2022 Habig Scott Michael Chief Commercial Officer Buy 91.3 +5,000 100.00% ✗ $25.1K
Nov 7, 2022 Nov 9, 2022 Martin Michael Robert Chief Business Officer Buy 95.0 +30,000 50.41% ✗ $154.8K
Aug 1, 2022 Aug 1, 2022 Knappertz Volker EVP, Research and Development Neutral 52.5 - 0.00% ✗ -
Aug 1, 2022 Aug 1, 2022 Habig Scott Michael Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jul 19, 2022 Knappertz Volker EVP, Research and Development Neutral 52.5 - 0.00% ✗ -
Jul 19, 2022 Habig Scott Michael Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
May 18, 2022 Jul 11, 2022 Jayne David R.W. Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 MILNE GEORGE M JR Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 MacKay-Dunn R. Hector Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 Billen Daniel Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 Walbert Timothy P Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 Jayne David R.W. Director Neutral 52.5 - 0.00% ✗ -
May 18, 2022 May 20, 2022 Leversage Jill Director Neutral 52.5 - 0.00% ✗ -